Please wait a minute...
文章检索
预防医学  2021, Vol. 33 Issue (3): 226-230    DOI: 10.19485/j.cnki.issn2096-5087.2021.03.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
文山州HIV/AIDS抗病毒治疗病例艾滋病羞辱和歧视的影响因素分析
胡晓松1, 吕华坤1, 王慎玉1, 赵燕2, 黄玲玲3, 吴尊友2
1.浙江省疾病预防控制中心免疫规划所,浙江 杭州 310051;
2.中国疾病预防控制中心性病艾滋病预防控制中心;
3.文山市人民医院抗病毒治疗门诊
Associated factors for HIV stigma among the patients on antiretroviral therapy in Wenshan Prefecture
HU Xiaosong*, LÜ Huakun, WANG Shenyu, ZHAO Yan, HUANG Lingling, WU Zunyou
*Department of Immunization Planning, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(868 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解云南省文山州抗病毒治疗门诊艾滋病病毒感染者和艾滋病患者(HIV/AIDS)艾滋病羞辱和歧视状况及影响因素,为消除艾滋病歧视提供参考。方法 于2017年10月—2018年1月,采用方便抽样方法选取文山州文山市和马关县3家艾滋病抗病毒治疗门诊治疗的HIV/AIDS病例进行问卷调查。采用李现红等编制的量表评估HIV/AIDS病例艾滋病羞辱和歧视状况。采用多重线性回归模型分析HIV/AIDS病例艾滋病羞辱和歧视的影响因素。结果 纳入HIV/AIDS病例419例,艾滋病羞辱和歧视总分中位数为68.00分,其中担心公开、内在羞辱、家庭歧视、公众歧视和医务人员歧视维度的得分中位数分别为24.00、20.00、10.00、6.00和2.00分。多重线性回归分析结果显示,女性(β'= 0.135)、发生机会性感染(β'= 0.120)、领取门诊激励礼物(β'= 0.124)的病例艾滋病羞辱和歧视评分较高;家人感染HIV(β'= -0.128)、获得家庭支持(β'= -0.175)、抗病毒治疗知识得分高(β'= -0.117)的病例艾滋病羞辱和歧视评分较低。结论 文山州艾滋病抗病毒治疗门诊HIV/AIDS病例担心公开和内在羞辱维度歧视情况较严重;性别、机会性感染、家人感染HIV、家庭支持、门诊激励礼物和抗病毒治疗认知是HIV/AIDS病例艾滋病羞辱和歧视的影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡晓松
吕华坤
王慎玉
赵燕
黄玲玲
吴尊友
关键词 艾滋病抗病毒治疗羞辱歧视    
AbstractObjective To learn HIV related stigma and its associated factors among the patients on antiretroviral therapy ( ART ) in Wenshan Prefecture, Yunnan Province, so as to provide evidence for eliminating HIV discrimination. Methods A total of 419 subjects were recruited by convenience sampling from three ART clinics in Wenshan City and Maguan County between October 2017 and January 2018. HIV/AIDS Related Stigma and Discrimination Scale developed by Li Xianhong et al was employed. The multivariate linear regression model were used to explore the influencing factors for HIV stigma. Results The median scores of disclosure concern, public rejection, family stigma, internalized stigma, health service providers' stigma were 24.00, 6.00, 10.00, 20.00, 2.00, respectively, and the overall was 68.00. The multivariate linear regression analysis showed that female patients ( standardized β=0.135 ) , patients with opportunistic infection ( standardized β=0.120 ), patients had no HIV infected family member ( standardized β=-0.128 ) , patients without family support ( standardized β=-0.175 ) , patients received gift from ART clinics ( standardized β=0.124 ) , patients scored lower in ART knowledge ( standardized β=-0.117 ) were likely to scored higher in HIV stigma. Conclusions The stigma on disclosure concern and internalized stigma dimensions are grievous among ART patients in Wenshan Prefecture. Gender, opportunistic infection, HIV infection in family, family support, receiving incentive gifts from clinics and awareness of ART are associated with HIV stigma.
Key wordsacquired immune deficiency syndrome    antiretroviral therapy    stigma    discrimination
收稿日期: 2020-10-26      出版日期: 2021-03-16
ZTFLH:  R512.91  
基金资助:艾滋病综合干预项目(XMSQ20171023_001)
通信作者: 吴尊友,E-mail:wuzy@263.net   
作者简介: 胡晓松,硕士,医师,主要从事传染病防控与疫苗临床研究工作
引用本文:   
胡晓松, 吕华坤, 王慎玉, 赵燕, 黄玲玲, 吴尊友. 文山州HIV/AIDS抗病毒治疗病例艾滋病羞辱和歧视的影响因素分析[J]. 预防医学, 2021, 33(3): 226-230.
HU Xiaosong, LÜ Huakun, WANG Shenyu, ZHAO Yan, HUANG Lingling, WU Zunyou. Associated factors for HIV stigma among the patients on antiretroviral therapy in Wenshan Prefecture. Preventive Medicine, 2021, 33(3): 226-230.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2021.03.003      或      http://www.zjyfyxzz.com/CN/Y2021/V33/I3/226
[1] 王科坤,杨银梅,姚星,等.武汉市HIV/AIDS病人感知歧视现状及相关因素分析[J] .中国艾滋病性病杂志,2018,24(7):667-670.
[2] KALICHMAN S,SHKEMBI B,HERNANDEZ D,et al.Income inequality,HIV stigma,and preventing HIV disease progression in rural communities[J] .Prev Sci,20(7):1066-1073.
[3] CORDEIRO DUTRA A F,CORDOVA W,AVANT F.Services,stigma,and discrimination:perceptions of African descendant men living with HIV/AIDS in Brazil and in the United States[J] .Soc Work Public Health,2018,33(4):226-236.
[4] 胡晓松,陈芳,丁凡,等.中国三城市HIV阳性男男性行为人群接受随访与抗病毒治疗服务状况及其影响因素分析[J] .中华预防医学杂志,2015,49(11):945-949.
[5] CHAMBERS L A,RUEDA S,BAKER D N,et al.Stigma,HIV and health:a qualitative synthesis[J] .BMC Public Health,2015,15:848.
[6] PANTELIC M,BOYES M,CLUVER L,et al.They say HIV is a punishment from god or from ancestors':cross-cultural adaptation and psychometric assessment of an HIV stigma scale for South African adolescents living with HIV(ALHIV-SS)[J] .Child Indic Res,2018,11(1):207-223.
[7] HUA J,EMRICK C B,GOLIN C E,et al.HIV and Stigma in Liuzhou,China[J] .AIDS Behav,2014,18(Suppl. 2):S203-S211.
[8] 李现红,何国平,王红红,等.HIV/AIDS相关羞辱和歧视量表的编制及评价[J] .中国护理杂志,2010,45(6):496-499.
[9] 陈然,王瑜,余建英,等.PHQ-9在综合医院住院患者中信效度研究[J] .四川精神卫生杂志,2017,30(2):149-153.
[10] 孙振晓,孙宇新,于相芬,等.广泛性焦虑量表在颈椎病患者焦虑情绪评估的信度和效度研究[J] .临床精神医学杂志,2017,27(4):250-252.
[11] 何筱衍,李春波,钱洁,等.广泛性焦虑量表在综合性医院的信度和效度研究[J] .上海精神医学杂志,2010,22(4):200-203.
[12] 胡晓松,赵燕,吴尊友.云南省文山州HIV感染者抗病毒治疗脱失影响因素的定性研究[J] .中华疾病控制杂志,2018,22(8):822-825.
[13] SIRIL H N,KAAYA S F,SMITH FAWZI M K,et al.Clinical outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam,Tanzania:a prospective cohort study[J] .AIDS Res Ther,2017,14(1):18.
[14] 罗珊霞,杨冬菊,黄霞,等.HIV感染者与AIDS患者感知歧视影响因素的横断面调查[J] .中国循证医学杂志,2018,18(6):560-564.
[15] LETSHWENYO-MARUATONA S B,MADISA M,BOITSHWARELO T,et al.Association between HIV/AIDS knowledge and stigma towards people living with HIV/AIDS in Botswana[J] .AJAR,2019,18(1):58-64.
[16] MANCINELLI S,NIELSEN-SAINES K,GERMANO P,et al.Who will be lost? Identifying patients at risk of loss to follow-up in Malawi.The DREAM Program Experience[J] .HIV Med,2017,18(8):573-579.
[17] NYBLADE L,STOCKTON M A,GIGER K,et al.Stigma in health facilities:why it matters and how we can change it[J] .BMC Med,2019,17(1):25.
[18] LEE H J,KIM D H,NA Y J,et al.Factors associated with HIV/AIDS-related stigma and discrimination by medical professionals in Korea:a survey of infectious disease specialists in Korea[J] .Niger J Clin Pract,2019,22(5):675-681.
[19] AKILIMALI P Z,MUSUMARI P M,KASHALA-ABOTNES E,et al.Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a(post-)conflict setting:a retrospective cohort study from Goma,Democratic Republic of Congo[J] .PLoS One,2017,12(2):e0171407.
[20] OJWANG'V O,PENNER J,BLAT C,et al.Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu,Kenya[J] .AIDS Care,2016,28(4):500-507.
[21] MBERI M N,KUONZA L R,DUBE N M,et al.Determinants of loss to follow-up in patients on antiretroviral treatment,South Africa,2004-2012:a cohort study[J] .BMC Health Serv Res,2015,15:259.
[22] 樊鹏飞,杨晴,毛宇嵘,等.江西省农村地区HIV感染者接受基层医疗卫生机构随访管理现状及相关因素分析[J] .中华流行病学杂志,2019,40(3):346-349.
[1] 张海云, 张润松, 肖招英, 应锡钧, 施治文. 嵊州市HIV/AIDS病例HAART治疗依从性的影响因素研究[J]. 预防医学, 2021, 33(3): 277-279.
[2] 王大勇, 赵淑珍, 叶振淼, 赵丽娜, 张鹤美, 苏德华, 陈向阳, 汪若秋, 梁奕晓, 侯祥庆, 毛广运. 2010-2018年温州市青年学生艾滋病哨点监测结果[J]. 预防医学, 2021, 33(2): 165-167.
[3] 孙群露, 周宗磊, 詹志强, 涂玉山, 陈晓燕, 李咸志, 栾荣生. 宝安区50岁及以上HIV/AIDS病例生存状况分析[J]. 预防医学, 2021, 33(2): 170-173.
[4] 贾和祥, 王飞, 陈幼凤, 马瞧勤. 萧山区50岁及以上男性HIV/AIDS病例确证前性行为特征[J]. 预防医学, 2021, 33(2): 181-184.
[5] 周涛, 李月飞, 白雪, 胡晓远, 马媛媛, 倪明健. 2005—2019年伊犁州抗病毒治疗吸毒人群HIV/AIDS病例生存分析[J]. 预防医学, 2021, 33(1): 25-30.
[6] 王建英, 卢巧玲, 许树红, 杨作凯, 单杏仁. 绍兴市新报告50岁及以上HIV/AIDS病例特征[J]. 预防医学, 2021, 33(1): 61-66.
[7] 张宏, 陈剑惠, 刘梅艳, 何鼎盛. 2011—2019年福州市经性接触传播的男性HIV/AIDS病例特征[J]. 预防医学, 2020, 32(9): 907-910.
[8] 罗艳, 赵刚, 黄思超, 罗文杰, 李西婷, 丁建明. 2013—2018年杭州市HIV/AIDS病例检测发现与晚发现影响因素研究[J]. 预防医学, 2020, 32(8): 757-761.
[9] 蒋均, 罗明宇, 杨介者, 何林, 徐云, 周欣. 2015—2019年浙江省新确证50岁及以上HIV/AIDS病例流行特征分析[J]. 预防医学, 2020, 32(8): 762-766.
[10] 王瑞, 张海兰, 黄晓丹, 卫晓丽. 西安市性病门诊男性就诊者艾滋病和性病监测结果[J]. 预防医学, 2020, 32(8): 813-816.
[11] 丁坚强, 项琼珊, 陈婉君, 刘巨敏. 镇海区性病患者HIV抗体检测及影响因素分析[J]. 预防医学, 2020, 32(6): 618-620.
[12] 王斌, 龚德光, 朱洁群. 鄞州区艾滋病抗病毒治疗患者生存率及影响因素分析[J]. 预防医学, 2020, 32(4): 346-350.
[13] 唐慧玲, 蒋均, 罗明宇, 金屡华, 王凤英, 潘晓红. 金华市2017年新确诊性接触传播HIV/AIDS本地感染病例特征及影响因素分析[J]. 预防医学, 2020, 32(4): 355-360.
[14] 张兴亮, 罗艳, 丁建明, 吴虹, 蒋均. 2017年杭州市新确诊男男性行为人群HIV/AIDS病例特征分析[J]. 预防医学, 2020, 32(4): 373-377.
[15] 卢江炜, 汤雪娟. 嘉兴市HIV感染孕产妇特征及艾滋病母婴阻断分析[J]. 预防医学, 2020, 32(4): 405-407.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed